In these experiments, we determined the reversal effect of poziotinib on the efficacy of specific anticancer drugs in colon cancer cells overexpressing the ABCG2 or ABCB1 transporters and in HEK293 cells transfected with the ABCG2 or ABCB1 gene. Here, ABCB1 is linked to colonic neoplasm.